Funding for this research was provided by:
Received: 19 December 2017
Accepted: 23 February 2018
First Online: 27 February 2018
Ethics approval and consent to participate
: This study received Ethics approval from the Ethics Commission for North-East and Central Switzerland (EKNZ 2014–110 Amendment) and adhered to the Declaration of Helsinki and the principles of good clinical practice.
: Not applicable
: Financial support for this study was provided by Novartis Pharma, Switzerland. The sponsor had no role in collection, analysis, and interpretation of data; writing of the paper; or in the decision to submit the paper for publication. Lucas Bachmann (LB), Livia Faes and Nicolas Bodmer are employees of medignition Inc. EB, RR and OR are employees of the Helsana Health Insurance Company, and Maximilian Kuhn is an employee of CSS Group. These funders provided support in the form of salaries but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.